Leap Biosystems
Space medicine technology
Leap Biosystems operates in the biosphere sector of the space industry, is headquartered in Canada, was founded in 2018, is self-funded, employs 11-50 people.
Leap Biosystems at a glance
| Status | Active |
|---|---|
| Sector | Biosphere |
| Headquarters | Canada |
| Founded | 2018 |
| Stage | Self-funded |
| Team size | 11-50 |
| Website | leapbiosystems.com |
Record last updated August 2026 · how we verify · spotted something outdated? Tell us.
Timeline & funding
- April 2022Achievement
- June 2019Company
- 2018CompanyFounded
Mission
Clinical medicine combined with new technology for human spaceflight, translated back to care on Earth.
Leap Biosystems practices space medicine from Halifax, Nova Scotia. Its president is Dave Williams, a physician and two-flight shuttle astronaut who once ran NASA's space and life sciences directorate, and the company gathers Canadian medical, aerospace and engineering professionals around a double purpose: medical care for people in space, and the same tools for people far from hospitals on Earth, in the Arctic, on expeditions, with the military.
Its most concrete public work was as payload integrator and trainer for Mark Pathy, the Canadian private astronaut on the Ax-1 mission in April 2022.
Since then the public record is quiet. The promised products, augmented reality and AI-assisted diagnostics for medical autonomy far from care, have not publicly shipped; the news page is empty and no funding is visible. The expertise is not in question. Whether there is a business attached to it has yet to be demonstrated.
Team
- Astronaut Dr. Dave Williams · CEO
- Dr. Nathalie Sleno · Executive VP
- Dr. Allyson Hindle · COO
- Dr. Meghan Grant · CTO
Follow startups like Leap Biosystems
Founder interviews and the most promising space startups, straight to your inbox. Free, no spam, unsubscribe anytime.